Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 11,087.89 | 9,408.43 | 4,481.32 | 2,799.37 |
Depreciation/ Depletion | 2,556.64 | 2,529.43 | 2,143.74 | 2,079.95 |
Non- Cash Items | -1,002.24 | 193.13 | -168.79 | -270.10 |
Changesin Working Capital | -506.02 | -6,604.97 | 2,569.72 | 1,561.15 |
Cashfrom Operating Activities | 12,136.27 | 5,526.02 | 9,025.99 | 6,170.37 |
Capital Expenditures | -2,201.81 | -2,085.58 | -1,495.04 | -1,170.13 |
Other Investing Cash Flow Items Total | 1,511.61 | -5,858.10 | -4,229.70 | 1,706.35 |
Cashfrom Investing Activities | -690.20 | -7,943.68 | -5,724.74 | 536.22 |
Financing Cash Flow Items | -298.96 | -100.09 | -269.18 | 68.63 |
Total Cash Dividends Paid | -2,898.17 | -2,518.88 | -2,158.92 | -1,559.47 |
Issuance( Retirement)of Debt Net | -3,513.03 | 4,995.04 | -2,765.36 | -4,489.64 |
Cashfrom Financing Activities | -6,710.16 | 2,376.07 | -5,193.46 | -5,980.48 |
Foreign Exchange Effects | -73.99 | 157.07 | 127.43 | -129.69 |
Net Changein Cash | 4,661.92 | 115.48 | -1,764.78 | 596.42 |
Cash Interest Paid | 219.03 | 99.24 | 73.21 | 144.25 |
Cash Taxes Paid | 1,569.44 | 1,509.84 | -969.22 | 1,002.94 |
Sun Pharmaceutical Industries Dividend Sun Pharmaceutical Industries Bonus Sun Pharmaceutical Industries News Sun Pharmaceutical Industries AGM Sun Pharmaceutical Industries Rights Sun Pharmaceutical Industries Splits Sun Pharmaceutical Industries Board Meetings Sun Pharmaceutical Industries Key Metrics Sun Pharmaceutical Industries Shareholdings Sun Pharmaceutical Industries Profit Loss Sun Pharmaceutical Industries Balance Sheet Sun Pharmaceutical Industries Q1 Results Sun Pharmaceutical Industries Q2 Results Sun Pharmaceutical Industries Q3 Results Sun Pharmaceutical Industries Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks